BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kalari S, Pfeifer GP. Identification of driver and passenger DNA methylation in cancer by epigenomic analysis. Adv Genet. 2010;70:277-308. [PMID: 20920752 DOI: 10.1016/b978-0-12-380866-0.60010-1] [Cited by in Crossref: 83] [Cited by in F6Publishing: 62] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Shen X, Li S, Zhang L, Li H, Hong G, Zhou X, Zheng T, Zhang W, Hao C, Shi T, Liu C, Guo Z. An integrated approach to uncover driver genes in breast cancer methylation genomes. PLoS One 2013;8:e61214. [PMID: 23579546 DOI: 10.1371/journal.pone.0061214] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
2 Abdallah MOE, Algizouli UK, Suliman MA, Abdulrahman RA, Koko M, Fessahaye G, Shakir JH, Fahal AH, Elhassan AM, Ibrahim ME, Mohamed HS. EBV Associated Breast Cancer Whole Methylome Analysis Reveals Viral and Developmental Enriched Pathways. Front Oncol 2018;8:316. [PMID: 30151354 DOI: 10.3389/fonc.2018.00316] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
3 Niskakoski A, Kaur S, Staff S, Renkonen-Sinisalo L, Lassus H, Järvinen HJ, Mecklin JP, Bützow R, Peltomäki P. Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation. Epigenetics 2014;9:1577-87. [PMID: 25625843 DOI: 10.4161/15592294.2014.983374] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
4 Lendvai Á, Johannes F, Grimm C, Eijsink JJ, Wardenaar R, Volders HH, Klip HG, Hollema H, Jansen RC, Schuuring E, Wisman GB, van der Zee AG. Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasia. Epigenetics 2012;7:1268-78. [PMID: 23018867 DOI: 10.4161/epi.22301] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
5 Kitchen MO, Bryan RT, Emes RD, Glossop JR, Luscombe C, Cheng KK, Zeegers MP, James ND, Devall AJ, Mein CA, Gommersall L, Fryer AA, Farrell WE. Quantitative genome-wide methylation analysis of high-grade non-muscle invasive bladder cancer. Epigenetics 2016;11:237-46. [PMID: 26929985 DOI: 10.1080/15592294.2016.1154246] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
6 De Carvalho DD, Sharma S, You JS, Su SF, Taberlay PC, Kelly TK, Yang X, Liang G, Jones PA. DNA methylation screening identifies driver epigenetic events of cancer cell survival. Cancer Cell. 2012;21:655-667. [PMID: 22624715 DOI: 10.1016/j.ccr.2012.03.045] [Cited by in Crossref: 168] [Cited by in F6Publishing: 148] [Article Influence: 18.7] [Reference Citation Analysis]
7 Hong C, Ning Y, Wang S, Wu H, Carroll RJ, Chen Y. PLMET: A Novel Pseudolikelihood-Based EM Test for Homogeneity in Generalilzed Exponential Tilt Mixture Models. J Am Stat Assoc 2017;112:1393-404. [PMID: 29416190 DOI: 10.1080/01621459.2017.1280405] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Long J, Chen P, Lin J, Bai Y, Yang X, Bian J, Lin Y, Wang D, Yang X, Zheng Y, Sang X, Zhao H. DNA methylation-driven genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma. Theranostics. 2019;9:7251-7267. [PMID: 31695766 DOI: 10.7150/thno.31155] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
9 Gu S, Lin S, Ye D, Qian S, Jiang D, Zhang X, Li Q, Yang J, Ying X, Li Z, Tang M, Wang J, Jin M, Chen K. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer. Clin Epigenetics 2019;11:41. [PMID: 30846004 DOI: 10.1186/s13148-019-0628-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
10 Ibragimova I, Slifker MJ, Maradeo ME, Banumathy G, Dulaimi E, Uzzo RG, Cairns P. Genome-wide promoter methylome of small renal masses. PLoS One 2013;8:e77309. [PMID: 24204800 DOI: 10.1371/journal.pone.0077309] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
11 Witte T, Plass C, Gerhauser C. Pan-cancer patterns of DNA methylation. Genome Med. 2014;6:66. [PMID: 25473433 DOI: 10.1186/s13073-014-0066-6] [Cited by in Crossref: 103] [Cited by in F6Publishing: 81] [Article Influence: 14.7] [Reference Citation Analysis]
12 Sanbhnani S, Yeong FM. CHFR: a key checkpoint component implicated in a wide range of cancers. Cell Mol Life Sci 2012;69:1669-87. [PMID: 22159584 DOI: 10.1007/s00018-011-0892-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
13 Tang H, Kan L, Ou T, Chen D, Dou X, Wu W, Ji X, Wang M, Zong Z, Mo H, Zhang X, Xiong D. Development of a novel prognostic signature for predicting the overall survival of bladder cancer patients. Biosci Rep 2020;40:BSR20194432. [PMID: 32441304 DOI: 10.1042/BSR20194432] [Reference Citation Analysis]
14 Tajuddin SM, Hernandez DG, Chen BH, Noren Hooten N, Mode NA, Nalls MA, Singleton AB, Ejiogu N, Chitrala KN, Zonderman AB, Evans MK. Novel age-associated DNA methylation changes and epigenetic age acceleration in middle-aged African Americans and whites. Clin Epigenetics 2019;11:119. [PMID: 31426852 DOI: 10.1186/s13148-019-0722-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 12.5] [Reference Citation Analysis]
15 Pal R, Srivastava N, Chopra R, Gochhait S, Gupta P, Prakash N, Agarwal G, Bamezai RN. Investigation of DNA damage response and apoptotic gene methylation pattern in sporadic breast tumors using high throughput quantitative DNA methylation analysis technology. Mol Cancer 2010;9:303. [PMID: 21092294 DOI: 10.1186/1476-4598-9-303] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
16 Wang S. Method to detect differentially methylated loci with case-control designs using Illumina arrays. Genet Epidemiol 2011;35:686-94. [PMID: 21818777 DOI: 10.1002/gepi.20619] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
17 Pandiyan K, You JS, Yang X, Dai C, Zhou XJ, Baylin SB, Jones PA, Liang G. Functional DNA demethylation is accompanied by chromatin accessibility. Nucleic Acids Res. 2013;41:3973-3985. [PMID: 23408854 DOI: 10.1093/nar/gkt077] [Cited by in Crossref: 56] [Cited by in F6Publishing: 52] [Article Influence: 7.0] [Reference Citation Analysis]
18 Malousi A, Kouidou S, Tsagiopoulou M, Papakonstantinou N, Bouras E, Georgiou E, Tzimagiorgis G, Stamatopoulos K. MeinteR: A framework to prioritize DNA methylation aberrations based on conformational and cis-regulatory element enrichment. Sci Rep 2019;9:19148. [PMID: 31844073 DOI: 10.1038/s41598-019-55453-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Pacholska-Bogalska J, Myga-Nowak M, Ciepłuch K, Józefiak A, Kwaśniewska A, Goździcka-Józefiak A. Analysis of the coding sequence and expression of the coiled-coil α-helical rod protein 1 gene in normal and neoplastic epithelial cervical cells. Int J Mol Med 2012;29:669-76. [PMID: 22218424 DOI: 10.3892/ijmm.2012.877] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
20 Guerrero-Preston R, Herbstman J, Goldman LR. Epigenomic biomonitors: global DNA hypomethylation as a biodosimeter of life-long environmental exposures. Epigenomics 2011;3:1-5. [PMID: 22126146 DOI: 10.2217/epi.10.77] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
21 Stark A, Shin DJ, Wang TH. A sample-to-answer droplet magnetofluidic assay platform for quantitative methylation-specific PCR. Biomed Microdevices 2018;20:31. [PMID: 29594810 DOI: 10.1007/s10544-018-0276-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
22 Choi JD, Lee JS. Interplay between Epigenetics and Genetics in Cancer. Genomics Inform. 2013;11:164-173. [PMID: 24465226 DOI: 10.5808/gi.2013.11.4.164] [Cited by in Crossref: 82] [Cited by in F6Publishing: 41] [Article Influence: 10.3] [Reference Citation Analysis]
23 Zheng J, Xiong D, Sun X, Wang J, Hao M, Ding T, Xiao G, Wang X, Mao Y, Fu Y, Shen K, Wang J. Signification of Hypermethylated in Cancer 1 (HIC1) as Tumor Suppressor Gene in Tumor Progression. Cancer Microenviron 2012;5:285-93. [PMID: 22528874 DOI: 10.1007/s12307-012-0103-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
24 Rajendran BK, Deng CX. Characterization of potential driver mutations involved in human breast cancer by computational approaches. Oncotarget 2017;8:50252-72. [PMID: 28477017 DOI: 10.18632/oncotarget.17225] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 7.7] [Reference Citation Analysis]
25 Conti Ad, Kobets T, Escudero-Lourdes C, Montgomery B, Tryndyak V, Beland FA, Doerge DR, Pogribny IP. Dose- and time-dependent epigenetic changes in the livers of Fisher 344 rats exposed to furan. Toxicol Sci 2014;139:371-80. [PMID: 24614236 DOI: 10.1093/toxsci/kfu044] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
26 Umer M, Qureshi SA, Hashmi ZY, Raza A, Ahmad J, Rahman M, Iqbal M. Promoter hypermethylation of Wnt pathway inhibitors in hepatitis C virus - induced multistep hepatocarcinogenesis. Virol J. 2014;11:117. [PMID: 24947038 DOI: 10.1186/1743-422x-11-117] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
27 You JS, Jones PA. Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell. 2012;22:9-20. [PMID: 22789535 DOI: 10.1016/j.ccr.2012.06.008] [Cited by in Crossref: 652] [Cited by in F6Publishing: 568] [Article Influence: 72.4] [Reference Citation Analysis]
28 Chappell G, Kutanzi K, Uehara T, Tryndyak V, Hong HH, Hoenerhoff M, Beland FA, Rusyn I, Pogribny IP. Genetic and epigenetic changes in fibrosis-associated hepatocarcinogenesis in mice. Int J Cancer 2014;134:2778-88. [PMID: 24242335 DOI: 10.1002/ijc.28610] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
29 Carlsson E, Ranki A, Sipilä L, Karenko L, Abdel-Rahman WM, Ovaska K, Siggberg L, Aapola U, Ässämäki R, Häyry V, Niiranen K, Helle M, Knuutila S, Hautaniemi S, Peltomäki P, Krohn K. Potential role of a navigator gene NAV3 in colorectal cancer. Br J Cancer 2012;106:517-24. [PMID: 22173670 DOI: 10.1038/bjc.2011.553] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
30 King WD, Ashbury JE, Taylor SA, Tse MY, Pang SC, Louw JA, Vanner SJ. A cross-sectional study of global DNA methylation and risk of colorectal adenoma. BMC Cancer 2014;14:488. [PMID: 24998982 DOI: 10.1186/1471-2407-14-488] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
31 Sonnenschein C, Soto AM, Rangarajan A, Kulkarni P. Competing views on cancer. J Biosci 2014;39:281-302. [PMID: 24736160 DOI: 10.1007/s12038-013-9403-y] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
32 Kanda M, Sugimoto H, Kodera Y. Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma. World J Gastroenterol. 2015;21:10584-10597. [PMID: 26457018 DOI: 10.3748/wjg.v21.i37.10584] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 41] [Article Influence: 7.4] [Reference Citation Analysis]
33 Paska AV, Hudler P. Aberrant methylation patterns in cancer: a clinical view. Biochem Med (Zagreb) 2015;25:161-76. [PMID: 26110029 DOI: 10.11613/BM.2015.017] [Cited by in Crossref: 52] [Cited by in F6Publishing: 29] [Article Influence: 8.7] [Reference Citation Analysis]
34 Delpu Y, Cordelier P, Cho WC, Torrisani J. DNA methylation and cancer diagnosis. Int J Mol Sci 2013;14:15029-58. [PMID: 23873296 DOI: 10.3390/ijms140715029] [Cited by in Crossref: 86] [Cited by in F6Publishing: 92] [Article Influence: 10.8] [Reference Citation Analysis]
35 Clarke J, Penas C, Pastori C, Komotar RJ, Bregy A, Shah AH, Wahlestedt C, Ayad NG. Epigenetic pathways and glioblastoma treatment. Epigenetics 2013;8:785-95. [PMID: 23807265 DOI: 10.4161/epi.25440] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
36 Pogribny IP, Rusyn I. Environmental toxicants, epigenetics, and cancer. Adv Exp Med Biol 2013;754:215-32. [PMID: 22956504 DOI: 10.1007/978-1-4419-9967-2_11] [Cited by in Crossref: 80] [Cited by in F6Publishing: 62] [Article Influence: 8.9] [Reference Citation Analysis]
37 Pogribny IP, Rusyn I. Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma. Cancer Lett. 2014;342:223-230. [PMID: 22306342 DOI: 10.1016/j.canlet.2012.01.038] [Cited by in Crossref: 109] [Cited by in F6Publishing: 107] [Article Influence: 12.1] [Reference Citation Analysis]
38 Goncalves R, Warner WA, Luo J, Ellis MJ. New concepts in breast cancer genomics and genetics. Breast Cancer Res 2014;16:460. [PMID: 25606588 DOI: 10.1186/s13058-014-0460-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
39 Pradhan MP, Desai A, Palakal MJ. Systems biology approach to stage-wise characterization of epigenetic genes in lung adenocarcinoma. BMC Syst Biol 2013;7:141. [PMID: 24369052 DOI: 10.1186/1752-0509-7-141] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
40 Zhang X, Gao L, Liu ZP, Jia S, Chen L. Uncovering Driver DNA Methylation Events in Nonsmoking Early Stage Lung Adenocarcinoma. Biomed Res Int 2016;2016:2090286. [PMID: 27610367 DOI: 10.1155/2016/2090286] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
41 Liu Y, Hu Z. Identification of collaborative driver pathways in breast cancer. BMC Genomics 2014;15:605. [PMID: 25034939 DOI: 10.1186/1471-2164-15-605] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
42 Pfeifer GP. Defining Driver DNA Methylation Changes in Human Cancer. Int J Mol Sci 2018;19:E1166. [PMID: 29649096 DOI: 10.3390/ijms19041166] [Cited by in Crossref: 117] [Cited by in F6Publishing: 93] [Article Influence: 39.0] [Reference Citation Analysis]
43 Jin SG, Xiong W, Wu X, Yang L, Pfeifer GP. The DNA methylation landscape of human melanoma. Genomics 2015;106:322-30. [PMID: 26384656 DOI: 10.1016/j.ygeno.2015.09.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
44 Lahtz C, Kim SI, Bates SE, Li AX, Wu X, Pfeifer GP. UVB irradiation does not directly induce detectable changes of DNA methylation in human keratinocytes. F1000Res 2013;2:45. [PMID: 24555035 DOI: 10.12688/f1000research.2-45.v1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
45 Ping Y, Deng Y, Wang L, Zhang H, Zhang Y, Xu C, Zhao H, Fan H, Yu F, Xiao Y, Li X. Identifying core gene modules in glioblastoma based on multilayer factor-mediated dysfunctional regulatory networks through integrating multi-dimensional genomic data. Nucleic Acids Res 2015;43:1997-2007. [PMID: 25653168 DOI: 10.1093/nar/gkv074] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
46 Qasim BJ, Al-Wasiti EA, Azzal HS. Association of global DNA hypomethylation with clinicopathological variables in colonic tumors of Iraqi patients. Saudi J Gastroenterol 2016;22:139-47. [PMID: 26997221 DOI: 10.4103/1319-3767.178525] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
47 Hahn MA, Li AX, Wu X, Yang R, Drew DA, Rosenberg DW, Pfeifer GP. Loss of the polycomb mark from bivalent promoters leads to activation of cancer-promoting genes in colorectal tumors. Cancer Res. 2014;74:3617-3629. [PMID: 24786786 DOI: 10.1158/0008-5472.can-13-3147] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 4.1] [Reference Citation Analysis]
48 Fernandez Tde S, de Souza Fernandez C, Mencalha AL. Human induced pluripotent stem cells from basic research to potential clinical applications in cancer. Biomed Res Int 2013;2013:430290. [PMID: 24288679 DOI: 10.1155/2013/430290] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
49 Sproul D, Meehan RR. Genomic insights into cancer-associated aberrant CpG island hypermethylation. Brief Funct Genomics 2013;12:174-90. [PMID: 23341493 DOI: 10.1093/bfgp/els063] [Cited by in Crossref: 86] [Cited by in F6Publishing: 75] [Article Influence: 10.8] [Reference Citation Analysis]
50 Hosoda K, Yashima K, Tamoto A, Yamamoto S, Kawata S, Ikebuchi Y, Matsumoto K, Kawaguchi K, Harada K, Murawaki Y, Isomoto H. Expression of methylation-modulated tumor-related genes in endoscopically resected early esophageal squamous neoplasia. Oncol Lett 2017;14:737-42. [PMID: 28693228 DOI: 10.3892/ol.2017.6196] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 Mikeska T, Craig JM. DNA methylation biomarkers: cancer and beyond. Genes (Basel). 2014;5:821-864. [PMID: 25229548 DOI: 10.3390/genes5030821] [Cited by in Crossref: 162] [Cited by in F6Publishing: 134] [Article Influence: 23.1] [Reference Citation Analysis]
52 Sánchez-Vega F, Gotea V, Margolin G, Elnitski L. Pan-cancer stratification of solid human epithelial tumors and cancer cell lines reveals commonalities and tissue-specific features of the CpG island methylator phenotype. Epigenetics Chromatin 2015;8:14. [PMID: 25960768 DOI: 10.1186/s13072-015-0007-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
53 Sun X, Yi J, Yang J, Han Y, Qian X, Liu Y, Li J, Lu B, Zhang J, Pan X, Liu Y, Liang M, Chen E, Liu P, Lu Y. An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance. Theranostics 2021;11:5346-64. [PMID: 33859751 DOI: 10.7150/thno.58385] [Reference Citation Analysis]
54 Padilla-Nash HM, Hathcock K, McNeil NE, Mack D, Hoeppner D, Ravin R, Knutsen T, Yonescu R, Wangsa D, Dorritie K, Barenboim L, Hu Y, Ried T. Spontaneous transformation of murine epithelial cells requires the early acquisition of specific chromosomal aneuploidies and genomic imbalances. Genes Chromosomes Cancer 2012;51:353-74. [PMID: 22161874 DOI: 10.1002/gcc.21921] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
55 Araujo-Castro M, Pascual-Corrales E, Molina-Cerrillo J, Alonso-Gordoa T. Immunotherapy in Adrenocortical Carcinoma: Predictors of Response, Efficacy, Safety, and Mechanisms of Resistance. Biomedicines 2021;9:304. [PMID: 33809752 DOI: 10.3390/biomedicines9030304] [Reference Citation Analysis]
56 Misawa K, Misawa Y, Imai A, Mochizuki D, Endo S, Mima M, Ishikawa R, Kawasaki H, Yamatodani T, Kanazawa T. Epigenetic modification of SALL1 as a novel biomarker for the prognosis of early stage head and neck cancer. J Cancer 2018;9:941-9. [PMID: 29581773 DOI: 10.7150/jca.23527] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
57 Kalari S, Jung M, Kernstine KH, Takahashi T, Pfeifer GP. The DNA methylation landscape of small cell lung cancer suggests a differentiation defect of neuroendocrine cells. Oncogene 2013;32:3559-68. [PMID: 22907430 DOI: 10.1038/onc.2012.362] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
58 Jung M, Kadam S, Xiong W, Rauch TA, Jin SG, Pfeifer GP. MIRA-seq for DNA methylation analysis of CpG islands. Epigenomics 2015;7:695-706. [PMID: 25881900 DOI: 10.2217/epi.15.33] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
59 Lokk K, Vooder T, Kolde R, Välk K, Võsa U, Roosipuu R, Milani L, Fischer K, Koltsina M, Urgard E, Annilo T, Metspalu A, Tõnisson N. Methylation markers of early-stage non-small cell lung cancer. PLoS One 2012;7:e39813. [PMID: 22768131 DOI: 10.1371/journal.pone.0039813] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 5.1] [Reference Citation Analysis]
60 Tan H, Bao J, Zhou X. Genome-wide mutational spectra analysis reveals significant cancer-specific heterogeneity. Sci Rep 2015;5:12566. [PMID: 26212640 DOI: 10.1038/srep12566] [Cited by in Crossref: 62] [Cited by in F6Publishing: 49] [Article Influence: 10.3] [Reference Citation Analysis]
61 Miura T, Ishiguro M, Ishikawa T, Okazaki S, Baba H, Kikuchi A, Yamauchi S, Matsuyama T, Uetake H, Kinugasa Y. Methylation of bone morphogenetic protein 2 is associated with poor prognosis in colorectal cancer. Oncol Lett 2020;19:229-38. [PMID: 31897134 DOI: 10.3892/ol.2019.11091] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
62 Kitchen MO, Bryan RT, Haworth KE, Emes RD, Luscombe C, Gommersall L, Cheng KK, Zeegers MP, James ND, Devall AJ, Fryer AA, Farrell WE. Methylation of HOXA9 and ISL1 Predicts Patient Outcome in High-Grade Non-Invasive Bladder Cancer. PLoS One 2015;10:e0137003. [PMID: 26332997 DOI: 10.1371/journal.pone.0137003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]